Jaclyn Cadaoas

Ultragenyx Pharmaceutical (United States)

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Galactosialidosis: preclinical enzyme replacement therapy in a mouse model of the disease, a proof of concept”.

Galactosialidosis: preclinical enzyme replacement therapy in a mouse model of the disease, a proof of concept

Molecular Therapy — Methods & Clinical Development(2020)10.1016/j.omtm.2020.11.012

N/A

0DataRank · unranked

20 citations

Huimin Hu, Gabrielle Boyle, Elida Gomero, Rosario Mosca, Kartika Jayashankar +10 more

Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with mucopolysaccharidosis type VII

Science Translational Medicine(2020)10.1126/scitranslmed.aay8980

N/A

0DataRank · unranked

40 citations

Russell G. Witt, Bowen Wang, Carlo Eikani, Jeremy M. Shea, Lucas K. Smith +7 more

Conventional and Unconventional Therapeutic Strategies for Sialidosis Type I

Journal of Clinical Medicine(2020)10.3390/jcm9030695

N/A

0DataRank · unranked

28 citations

Diantha van de Vlekkert, Yvan Campos, Leigh E. Fremuth, Jaclyn Cadaoas, Vish Koppaka +10 more